Newly approved asenapine promising for acute episodes of schizophrenia
Mood stabilizer equal to combination treatment for acute bipolar depression
Reboxetine and triiodothyronine may lead to adverse events
D-Cycloserine for enhancing response to CBT for panic disorder
Testosterone gel add-on to antidepressants in men with MDD
Commentary by Roger S. McIntyre, M.D., FRCPC
News Note
Successful clozapine rechallenge in refractory schizophrenia
From the FDA